- Total Pro Portfolios with MYL:
- Fairholme FAIRX
- Third Point LLC
- Intrepid Capital Management
- Clarium Capital
- show more
- 7
- ProFunds Pharmaceuticals UltraSector Inv PHPIX
- Duquesne Capital
- ProFunds Pharmaceuticals UltraSector - PHPSX
- Total Do-It-Yourself Portfolios with MYL:
- A4 Quality Returns
- Castoa Portfolio 1
- Harvey Lisch Portfolio 1
- gamester Portfolio 1
- Motmouth Portfolio 1
- Johnsys Portfolio 1
- mlcwork Portfolio 1
- lpm Portfolio 1
- Gary Witham Portfolio 1
- rick weitz Portfolio 1
- eerasmus Portfolio 1
- Sachin's Value Equities
- btRemoved
- msathena277 Portfolio 1
- mercedes0722 Portfolio 1
- janedo0722 Portfolio 1
- SUPRATRADE-QUANTUM MEGA 7
- JWS First Port
- Portfolio AA
- raf1177106 Portfolio 1
- optionsFREAKSHOW
- SUPRATRADE GEMINI II
- SUPRATRADE 1104070303 Failing Down
- kokakis Portfolio 1
- BK in MD Portfolio 1
- akfyzhou New Holding
- oldtoad Portfolio 1
- vans
- petelakeland Portfolio 1
- pat & hals
- first spark
- Profile No. 1
- willieb33 Value Shorts
- lpiefke Portfolio 1
- carlw414 Portfolio 1
- rms june 1107
- Laurie
- Insider Purchases and Buybacks X
- cdisston Portfolio 1
- RiskMan portfolio
- manoncamelshump diversified retirement
- rmcdonald5303 Portfolio 1
- MINE 1 / i own
- mdmel5 Portfolio 1
- Distress
- eric1234567 Portfolio 1
- CARBOB Portfolio 1
- SUPRATRADE "BUY IT ALL TODAY" 0708071331(7.august)
- Nicholai Portfolio 1
- The Future Of Techno
- ellen tratnik Portfolio 1
- show more
- 163
- LOVEMARY
- AGE Anna
- big&tall
- Peter Leung Portfolio 1
- DblD01
- PRAVIN M. PATEL Portfolio 1
- BOB GLAZER Portfolio 1
- R A C Portfolio 1
- Amp pick
- Unreasonably Discounted Growth
- Jeff Miller Portfolio 1
- DADS
- BMWINTHESHOP Portfolio 1
- msathena722 Portfolio 1
- babygal0722 Portfolio 1
- yowat Portfolio 1
- dtauch Portfolio 1
- sweetdreamz Portfolio 1
- webkng Portfolio 1
- GVC's Faves 1
- robin2413 Portfolio 1
- SUPRATRADE 1104070235
- jz17 Portfolio 1
- obcek Portfolio 1
- SUPRATRADE QUANT XIII
- mbrowning1 Portfolio 1
- zstar12's value watch
- lorenzo187 Portfolio 1
- heabu Portfolio 1
- mgvision1 Portfolio 1
- Generic Drug Manufacturers
- melnyk
- thorpesommer Portfolio 1
- fyutka Portfolio 1
- Pharms
- ricknyc Portfolio 1
- Barron's Insider Purchases 6-25-07
- timm123 Portfolio 1
- Mark Winner Portfolio 1
- Manu's Portfolio
- GBains Portfolio 1
- retire at 50
- gad11 Portfolio 1
- navneer Portfolio 1
- raghubhardwaj Portfolio 1
- cajoku Portfolio 1
- vtmon Portfolio 1
- cauthren
- elawshe Portfolio 1
- 7ladderchamp Portfolio 1
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:09 23 09 |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:09 05 09 |
"The key issue to focus on in the next four months is top-line revenue growth," says David Kostin, Goldman Sachs' chief U.S. strategist. Since peaking at $91 a share in mid-2007, S&P 500 profits have suffered the worst contraction since the Great Depression, falling 53%. During this stretch, companies have cut jobs, slashed fixed costs and amassed considerable operating leverage that can come in handy when revenue grows again. Kostin thinks companies exposed to the faster-growing economies of Brazil, Russia, India and China are better positioned to deliver such growth. To that end, Goldman has flagged a basket of 50 U.S. stocks with the highest percentage of sales to these BRIC countries. The selection includes Sohu.com (ticker: SOHU), Marvell Technology (MRVL), Mylan Laboratories (MYL), Pfizer (PFE), Morgan Stanley (MS) and Yum! Brands (YUM). |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:07 28 09 |
Pete Najarian has spotted unusual options activity in Mylan Labs (MYL). The large number of September 15 calls trading suggests that options investors are betting the stock could make a significant move higher, Najarian explains. |
|
Not yet rated
Rate now:
|
|
By:gross641 |
Date:07 23 09 |
Swing trade from a huge gain in Watson Pharmaceuticals, Mylan has an excelent portfolio of generics after their aquisition of Merck KGA. Balance sheet is a little scary but I am confident the company can work down its debt |
|
Not yet rated
Rate now:
|
|
Date:04 28 09 |
|
12.1 |
|
Not yet rated
Rate now:
|
|
Date:02 24 09 |
|
Generic Drugs take over |
|
Not yet rated
Rate now:
|
|
Date:12 30 08 |
|
8:30 |
|
Not yet rated
Rate now:
|
|
By:pomerantz |
Date:12 26 08 |
new administration friendly to generics |
|
Not yet rated
Rate now:
|
|
By:repoman535 |
Date:10 17 08 |
Again...made $$ |
|
Not yet rated
Rate now:
|
|
By:schmls |
Date:04 23 08 |
Look at your formulary....they play in huge arena |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
Date:03 31 08 |
|
poor price performance |
|
Not yet rated
Rate now:
|
|
By:jwd1226 |
Date:03 04 08 |
poor management |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:09 01 07 |
On the downswing in the past six months, with low grades that suggest the stocks will be culled. Mylan Laboratories is down to 49.8 |
|
Not yet rated
Rate now:
|
|
By:dragonslayer |
Date:08 29 07 |
own |
|
Not yet rated
Rate now:
|
|








